Review



immunofluorescence blocking solution  (Sangon Biotech)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Sangon Biotech immunofluorescence blocking solution
    The Effect of IGF2BP2 on the Proliferation and Differentiation of Myoblasts. (A) CCK-8 assay assessing cell proliferation following transfection with pcDNA3.1-IGF2BP2 or the negative control pcDNA3.1 at 0, 24, 48, 72, and 96 h (mean ± SEM; within each time point, significance between experimental group and control group was denoted as * P < 0.05; ** P < 0.01; n = 4). (B) EdU assay performed 48 h post-transfection to evaluate cell proliferation (20 ×, scale 50 µm) (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (C) The relative mRNA expression levels of IGF2BP2 and proliferation markers genes ( PCNA, CCND1 , and CDK2 ) 48 h after transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (D) Relative protein levels of proliferation markers ( PCNA and CDK2 ) 48 h after transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 3). (E) <t>Immunofluorescence</t> staining with MyHC (200 × magnification) after transfection. Cells were stained for MyHC in red serving as myogenic marker and DAPI in blue represents the nucleus. The right graph quantifies the relative myotube area (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (F) Relative mRNA expression levels of IGF2BP2 and myogenic differentiation markers, including MyHC, MyoD1, MyoG , and Myomaker after 3 days of differentiation induction (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (G) Relative protein levels of myogenic differentiation markers (MyHC, MyoD1) post-transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 3).
    Immunofluorescence Blocking Solution, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/immunofluorescence+blocking+solution/blocking+buffer+immunostaining/pmc13000497-150-6-9
    Average 86 stars, based on 1 article reviews
    immunofluorescence blocking solution - by Bioz Stars, 2026-08
    86/100 stars

    Images

    1) Product Images from "Double-negative feedback loop between IGF2BP2 and miR-196-5p inhibits the proliferation and differentiation of primary chicken myoblasts"

    Article Title: Double-negative feedback loop between IGF2BP2 and miR-196-5p inhibits the proliferation and differentiation of primary chicken myoblasts

    Journal: Poultry Science

    doi: 10.1016/j.psj.2026.106746

    The Effect of IGF2BP2 on the Proliferation and Differentiation of Myoblasts. (A) CCK-8 assay assessing cell proliferation following transfection with pcDNA3.1-IGF2BP2 or the negative control pcDNA3.1 at 0, 24, 48, 72, and 96 h (mean ± SEM; within each time point, significance between experimental group and control group was denoted as * P < 0.05; ** P < 0.01; n = 4). (B) EdU assay performed 48 h post-transfection to evaluate cell proliferation (20 ×, scale 50 µm) (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (C) The relative mRNA expression levels of IGF2BP2 and proliferation markers genes ( PCNA, CCND1 , and CDK2 ) 48 h after transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (D) Relative protein levels of proliferation markers ( PCNA and CDK2 ) 48 h after transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 3). (E) Immunofluorescence staining with MyHC (200 × magnification) after transfection. Cells were stained for MyHC in red serving as myogenic marker and DAPI in blue represents the nucleus. The right graph quantifies the relative myotube area (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (F) Relative mRNA expression levels of IGF2BP2 and myogenic differentiation markers, including MyHC, MyoD1, MyoG , and Myomaker after 3 days of differentiation induction (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (G) Relative protein levels of myogenic differentiation markers (MyHC, MyoD1) post-transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 3).
    Figure Legend Snippet: The Effect of IGF2BP2 on the Proliferation and Differentiation of Myoblasts. (A) CCK-8 assay assessing cell proliferation following transfection with pcDNA3.1-IGF2BP2 or the negative control pcDNA3.1 at 0, 24, 48, 72, and 96 h (mean ± SEM; within each time point, significance between experimental group and control group was denoted as * P < 0.05; ** P < 0.01; n = 4). (B) EdU assay performed 48 h post-transfection to evaluate cell proliferation (20 ×, scale 50 µm) (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (C) The relative mRNA expression levels of IGF2BP2 and proliferation markers genes ( PCNA, CCND1 , and CDK2 ) 48 h after transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (D) Relative protein levels of proliferation markers ( PCNA and CDK2 ) 48 h after transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 3). (E) Immunofluorescence staining with MyHC (200 × magnification) after transfection. Cells were stained for MyHC in red serving as myogenic marker and DAPI in blue represents the nucleus. The right graph quantifies the relative myotube area (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (F) Relative mRNA expression levels of IGF2BP2 and myogenic differentiation markers, including MyHC, MyoD1, MyoG , and Myomaker after 3 days of differentiation induction (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (G) Relative protein levels of myogenic differentiation markers (MyHC, MyoD1) post-transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 3).

    Techniques Used: CCK-8 Assay, Transfection, Negative Control, Control, EdU Assay, Expressing, Immunofluorescence, Staining, Marker, Cell Characterization

    IGF2BP2 and miR-196-5p regulate chicken myoblasts differentiation. (A) Immunofluorescence analysis of MyHC cells after co-transfection (200x magnification) (mean ± SEM; n = 4). a, b Among different groups, values with different lowercase superscripts denote significant differences ( P < 0.05). (B) Relative mRNA expression of the myogenic differentiation markers (mean ± SEM; n = 4). a, b Among different groups, values with different lowercase superscripts denote significant differences ( P < 0.05). (C) Protein relative expression levels of myogenic differentiation markers. (mean ± SEM; n = 2). a, b Among different groups, values with different lowercase superscripts denote significant differences ( P < 0.05).
    Figure Legend Snippet: IGF2BP2 and miR-196-5p regulate chicken myoblasts differentiation. (A) Immunofluorescence analysis of MyHC cells after co-transfection (200x magnification) (mean ± SEM; n = 4). a, b Among different groups, values with different lowercase superscripts denote significant differences ( P < 0.05). (B) Relative mRNA expression of the myogenic differentiation markers (mean ± SEM; n = 4). a, b Among different groups, values with different lowercase superscripts denote significant differences ( P < 0.05). (C) Protein relative expression levels of myogenic differentiation markers. (mean ± SEM; n = 2). a, b Among different groups, values with different lowercase superscripts denote significant differences ( P < 0.05).

    Techniques Used: Immunofluorescence, Cotransfection, Expressing, Cell Characterization



    Similar Products

    immunofluorescence blocking solution  (Sangon Biotech)
    86
    Sangon Biotech immunofluorescence blocking solution
    The Effect of IGF2BP2 on the Proliferation and Differentiation of Myoblasts. (A) CCK-8 assay assessing cell proliferation following transfection with pcDNA3.1-IGF2BP2 or the negative control pcDNA3.1 at 0, 24, 48, 72, and 96 h (mean ± SEM; within each time point, significance between experimental group and control group was denoted as * P < 0.05; ** P < 0.01; n = 4). (B) EdU assay performed 48 h post-transfection to evaluate cell proliferation (20 ×, scale 50 µm) (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (C) The relative mRNA expression levels of IGF2BP2 and proliferation markers genes ( PCNA, CCND1 , and CDK2 ) 48 h after transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (D) Relative protein levels of proliferation markers ( PCNA and CDK2 ) 48 h after transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 3). (E) <t>Immunofluorescence</t> staining with MyHC (200 × magnification) after transfection. Cells were stained for MyHC in red serving as myogenic marker and DAPI in blue represents the nucleus. The right graph quantifies the relative myotube area (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (F) Relative mRNA expression levels of IGF2BP2 and myogenic differentiation markers, including MyHC, MyoD1, MyoG , and Myomaker after 3 days of differentiation induction (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (G) Relative protein levels of myogenic differentiation markers (MyHC, MyoD1) post-transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 3).
    Immunofluorescence Blocking Solution, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/immunofluorescence+blocking+solution/blocking+buffer+immunostaining/pmc13000497-150-6-9
    Average 86 stars, based on 1 article reviews
    immunofluorescence blocking solution - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier
    blocking solution  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc blocking solution
    The Effect of IGF2BP2 on the Proliferation and Differentiation of Myoblasts. (A) CCK-8 assay assessing cell proliferation following transfection with pcDNA3.1-IGF2BP2 or the negative control pcDNA3.1 at 0, 24, 48, 72, and 96 h (mean ± SEM; within each time point, significance between experimental group and control group was denoted as * P < 0.05; ** P < 0.01; n = 4). (B) EdU assay performed 48 h post-transfection to evaluate cell proliferation (20 ×, scale 50 µm) (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (C) The relative mRNA expression levels of IGF2BP2 and proliferation markers genes ( PCNA, CCND1 , and CDK2 ) 48 h after transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (D) Relative protein levels of proliferation markers ( PCNA and CDK2 ) 48 h after transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 3). (E) <t>Immunofluorescence</t> staining with MyHC (200 × magnification) after transfection. Cells were stained for MyHC in red serving as myogenic marker and DAPI in blue represents the nucleus. The right graph quantifies the relative myotube area (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (F) Relative mRNA expression levels of IGF2BP2 and myogenic differentiation markers, including MyHC, MyoD1, MyoG , and Myomaker after 3 days of differentiation induction (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (G) Relative protein levels of myogenic differentiation markers (MyHC, MyoD1) post-transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 3).
    Blocking Solution, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/immunofluorescence+blocking+solution/Immunofluorescence+Blocking+Buffer/pm41904944-288-23-33
    Average 96 stars, based on 1 article reviews
    blocking solution - by Bioz Stars, 2026-08
    96/100 stars
    		  Buy from Supplier
    excess blocking solution  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc excess blocking solution
    The Effect of IGF2BP2 on the Proliferation and Differentiation of Myoblasts. (A) CCK-8 assay assessing cell proliferation following transfection with pcDNA3.1-IGF2BP2 or the negative control pcDNA3.1 at 0, 24, 48, 72, and 96 h (mean ± SEM; within each time point, significance between experimental group and control group was denoted as * P < 0.05; ** P < 0.01; n = 4). (B) EdU assay performed 48 h post-transfection to evaluate cell proliferation (20 ×, scale 50 µm) (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (C) The relative mRNA expression levels of IGF2BP2 and proliferation markers genes ( PCNA, CCND1 , and CDK2 ) 48 h after transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (D) Relative protein levels of proliferation markers ( PCNA and CDK2 ) 48 h after transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 3). (E) <t>Immunofluorescence</t> staining with MyHC (200 × magnification) after transfection. Cells were stained for MyHC in red serving as myogenic marker and DAPI in blue represents the nucleus. The right graph quantifies the relative myotube area (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (F) Relative mRNA expression levels of IGF2BP2 and myogenic differentiation markers, including MyHC, MyoD1, MyoG , and Myomaker after 3 days of differentiation induction (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (G) Relative protein levels of myogenic differentiation markers (MyHC, MyoD1) post-transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 3).
    Excess Blocking Solution, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/immunofluorescence+blocking+solution/Immunofluorescence+Blocking+Buffer/pmc12885997-142-3-17
    Average 96 stars, based on 1 article reviews
    excess blocking solution - by Bioz Stars, 2026-08
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    The Effect of IGF2BP2 on the Proliferation and Differentiation of Myoblasts. (A) CCK-8 assay assessing cell proliferation following transfection with pcDNA3.1-IGF2BP2 or the negative control pcDNA3.1 at 0, 24, 48, 72, and 96 h (mean ± SEM; within each time point, significance between experimental group and control group was denoted as * P < 0.05; ** P < 0.01; n = 4). (B) EdU assay performed 48 h post-transfection to evaluate cell proliferation (20 ×, scale 50 µm) (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (C) The relative mRNA expression levels of IGF2BP2 and proliferation markers genes ( PCNA, CCND1 , and CDK2 ) 48 h after transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (D) Relative protein levels of proliferation markers ( PCNA and CDK2 ) 48 h after transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 3). (E) Immunofluorescence staining with MyHC (200 × magnification) after transfection. Cells were stained for MyHC in red serving as myogenic marker and DAPI in blue represents the nucleus. The right graph quantifies the relative myotube area (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (F) Relative mRNA expression levels of IGF2BP2 and myogenic differentiation markers, including MyHC, MyoD1, MyoG , and Myomaker after 3 days of differentiation induction (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (G) Relative protein levels of myogenic differentiation markers (MyHC, MyoD1) post-transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 3).

    Journal: Poultry Science

    Article Title: Double-negative feedback loop between IGF2BP2 and miR-196-5p inhibits the proliferation and differentiation of primary chicken myoblasts

    doi: 10.1016/j.psj.2026.106746

    Figure Lengend Snippet: The Effect of IGF2BP2 on the Proliferation and Differentiation of Myoblasts. (A) CCK-8 assay assessing cell proliferation following transfection with pcDNA3.1-IGF2BP2 or the negative control pcDNA3.1 at 0, 24, 48, 72, and 96 h (mean ± SEM; within each time point, significance between experimental group and control group was denoted as * P < 0.05; ** P < 0.01; n = 4). (B) EdU assay performed 48 h post-transfection to evaluate cell proliferation (20 ×, scale 50 µm) (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (C) The relative mRNA expression levels of IGF2BP2 and proliferation markers genes ( PCNA, CCND1 , and CDK2 ) 48 h after transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (D) Relative protein levels of proliferation markers ( PCNA and CDK2 ) 48 h after transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 3). (E) Immunofluorescence staining with MyHC (200 × magnification) after transfection. Cells were stained for MyHC in red serving as myogenic marker and DAPI in blue represents the nucleus. The right graph quantifies the relative myotube area (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (F) Relative mRNA expression levels of IGF2BP2 and myogenic differentiation markers, including MyHC, MyoD1, MyoG , and Myomaker after 3 days of differentiation induction (mean ± SEM; * P < 0.05; ** P < 0.01; n = 4). (G) Relative protein levels of myogenic differentiation markers (MyHC, MyoD1) post-transfection (mean ± SEM; * P < 0.05; ** P < 0.01; n = 3).

    Article Snippet: The cells were then blocked with immunofluorescence blocking solution (Sangon Biotechnology, Shanghai, China) for 1 h at room temperature.

    Techniques: CCK-8 Assay, Transfection, Negative Control, Control, EdU Assay, Expressing, Immunofluorescence, Staining, Marker, Cell Characterization

    IGF2BP2 and miR-196-5p regulate chicken myoblasts differentiation. (A) Immunofluorescence analysis of MyHC cells after co-transfection (200x magnification) (mean ± SEM; n = 4). a, b Among different groups, values with different lowercase superscripts denote significant differences ( P < 0.05). (B) Relative mRNA expression of the myogenic differentiation markers (mean ± SEM; n = 4). a, b Among different groups, values with different lowercase superscripts denote significant differences ( P < 0.05). (C) Protein relative expression levels of myogenic differentiation markers. (mean ± SEM; n = 2). a, b Among different groups, values with different lowercase superscripts denote significant differences ( P < 0.05).

    Journal: Poultry Science

    Article Title: Double-negative feedback loop between IGF2BP2 and miR-196-5p inhibits the proliferation and differentiation of primary chicken myoblasts

    doi: 10.1016/j.psj.2026.106746

    Figure Lengend Snippet: IGF2BP2 and miR-196-5p regulate chicken myoblasts differentiation. (A) Immunofluorescence analysis of MyHC cells after co-transfection (200x magnification) (mean ± SEM; n = 4). a, b Among different groups, values with different lowercase superscripts denote significant differences ( P < 0.05). (B) Relative mRNA expression of the myogenic differentiation markers (mean ± SEM; n = 4). a, b Among different groups, values with different lowercase superscripts denote significant differences ( P < 0.05). (C) Protein relative expression levels of myogenic differentiation markers. (mean ± SEM; n = 2). a, b Among different groups, values with different lowercase superscripts denote significant differences ( P < 0.05).

    Article Snippet: The cells were then blocked with immunofluorescence blocking solution (Sangon Biotechnology, Shanghai, China) for 1 h at room temperature.

    Techniques: Immunofluorescence, Cotransfection, Expressing, Cell Characterization